|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
19,500 |
|
|
Direct
Value |
$6,739,296 |
|
|
Indirect Value
|
$118,170 |
|
|
Total
Shares |
312,921 |
|
|
Total
Value |
$6,857,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
Percentage
Gain/Loss : |
-31.1%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
|
2005-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(106,667) |
24,133 |
|
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2012-12-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
261,200 |
|
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2013-08-15 |
4 |
B |
$4.50 |
$2,502 |
D/D |
556 |
261,756 |
2.31 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2014-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
361,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2014-11-20 |
4 |
B |
$8.20 |
$10,660 |
D/D |
1,300 |
363,056 |
2.81 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2014-11-21 |
4 |
B |
$8.50 |
$73,950 |
D/D |
8,700 |
371,756 |
2.81 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2015-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
368,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2015-11-09 |
4 |
AS |
$18.77 |
$563,100 |
D/D |
(30,000) |
338,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2015-11-10 |
4 |
AS |
$18.72 |
$561,600 |
D/D |
(30,000) |
308,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2016-01-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
305,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2016-11-21 |
4 |
S |
$21.00 |
$105,000 |
D/D |
(5,000) |
243,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2016-11-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
57,000 |
248,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2016-11-22 |
4 |
S |
$21.30 |
$68,160 |
D/D |
(3,200) |
240,556 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2017-06-14 |
4 |
S |
$17.85 |
$89,250 |
D/D |
(5,000) |
245,556 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2017-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
240,556 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2017-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,000 |
217,556 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,549 |
221,105 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-03-07 |
4 |
OE |
$6.00 |
$1,668 |
D/D |
278 |
221,383 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
245,883 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-08-31 |
4 |
AS |
$32.00 |
$384,000 |
D/D |
(12,000) |
245,883 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-08-31 |
4 |
OE |
$8.70 |
$104,400 |
D/D |
12,000 |
257,883 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
264,383 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-11-14 |
4 |
AS |
$23.63 |
$131,735 |
D/D |
(5,550) |
258,833 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-11-15 |
4 |
AS |
$24.21 |
$134,969 |
D/D |
(5,550) |
253,283 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,750 |
251,533 |
0 |
- |
|
169 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|